HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Cool Mint Listerine PocketPaks

This article was originally published in The Tan Sheet

Executive Summary

Planned January launch indefinitely postponed due to production problems, Warner-Lambert Consumer Group acknowledges Dec. 14. Dissolvable oral care strips containing Listerine essential oils originally was slated for an August launch, which also was pushed back because of better-than-expected demand (1"The Tan Sheet" July 3, p. 15). The product will not be on shelves until late 2001 at the earliest, firm says; PocketPaks have been on sale in Canada since June

You may also be interested in...



Warner-Lambert

Cool Mint Listerine PocketPaks breath strips launch delayed, firm acknowledges. The new launch date is Jan. 16. The product, a novel delivery form of Listerine's essential oils, was slated for an August debut (1"The Tan Sheet" Feb. 28, p. 3). W-L cited Better-than-expected demand from retailers as the reason for the postponement. W-L also is developing a relaunch of its Listerine toothpaste

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

In Brief

Combe sells most of its OTC brands

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS132846

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel